Radiofrequency Ablation (RFA) in Breast Tumors

NCT ID: NCT04389216

Last Updated: 2025-09-15

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-05-01

Study Completion Date

2025-09-09

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To validate the efficacy and safety of the cool-tip ablation method for breast tumors smaller than 2 cm.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A prospective, phase II-III study, which will include a series of cases of 30 patients. The hospitals involved will be Bellvitge University Hospital and Hospital del Mar.

Efficacy was evaluated according magnetic resonance image and biopsy of the breast 1 month after the procedure.

Patients will be followed up over a 2-year period to assess cosmetic results, short and long-term complications and possible recurrences.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Breast Cancer Female

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Radiofrequency ablation
Primary Study Purpose

TREATMENT

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Radiofrequency Ablation Tumor

Radiofrequency Ablation of breast cancer tumour by Cool-tip electrode.

Group Type EXPERIMENTAL

Cool-tip electrode for Radiofrequency Ablation

Intervention Type DEVICE

Radiofrequency ablation of the tumour in the surgery group, associated whith axillary surgery when applicable

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Cool-tip electrode for Radiofrequency Ablation

Radiofrequency ablation of the tumour in the surgery group, associated whith axillary surgery when applicable

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Infiltrating ductal carcinoma according the biopsy of the breast,
* Tumor visible by ultrasound, smaller than 2 cm,
* Located \> 1 cm from the chest wall and the skin.

Exclusion Criteria

* Personal antecedents of breast cancer
* Multifocality or intraductal carcinoma
* Lobular infiltrating carcinoma
* Neoadjuvant therapy
Minimum Eligible Age

65 Years

Eligible Sex

FEMALE

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Hospital Universitari de Bellvitge

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Amparo Garcia-Tejedor

PRINCIPAL INVESTIGATOR

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Amparo Garcia-Tejedor, MDPhD

Role: PRINCIPAL_INVESTIGATOR

Hospital Universitari Bellvitge

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Hospital del Mar

Barcelona, Barcelona, Spain

Site Status

Hospital de Bellvitge

L'Hospitalet de Llobregat, Barcelona, Spain

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Spain

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

ICPS002/20

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Radiofrequency Ablation of Lung Tumors
NCT00180856 COMPLETED PHASE2
RFA vs. SBRT for Small HCC
NCT03898921 UNKNOWN PHASE3